Landscape of Prophylactic Strategies Against Human Parainfluenza Virus Type 3 [0.03%]
人副流感病毒3型的预防策略现状与展望
Clémence Vacher,Julia Dubois,Marie-Eve Hamelin et al.
Clémence Vacher et al.
Human parainfluenza virus-type 3 (HPIV3) is a respiratory virus responsible for mild illnesses in most of the population and severe illnesses, such as bronchiolitis and pneumonia, in young children, immunocompromised individuals and the eld...
Duration of protective immunity following COVID-19 vaccination of individuals with underlying health conditions: A rapid review [0.03%]
患有慢性疾病人群接种新冠疫苗后保护性免疫力的持续时间:快速综述
Kieran A Walsh,Helen ODonnell,Mark OLoughlin et al.
Kieran A Walsh et al.
The World Health Organization has stated that the primary goal of immunisation in the COVID-19 pandemic remains to protect against hospitalisation, severe disease and death. Vaccination is particularly important for those with underlying he...
The Dual Role of Autophagy in the Pathogenesis of Arboviruses With a Focus on JEV and DENV [0.03%]
自噬在虫媒病毒病原学中的双重作用——重点研究日本脑炎病毒和登革热病毒
HaoNing Wang,YuHan Wang,YuFei Li et al.
HaoNing Wang et al.
Japanese encephalitis virus (JEV) and dengue virus (DENV) are two major arboviruses known as significant public health issues worldwide. Arboviruses are a heterogeneous group of vector-borne viruses that are clinically associated with vario...
Database-Driven Surveillance of Lenacapavir Resistance Profiles in China: Analysis of HIV-1 Gag Sequences From People Living With HIV [0.03%]
在中国基于数据库的Lenacapavir耐药监测:对HIV-1衣壳蛋白序列的分析
Defu Yuan,Yangyang Liu,Yueqi Yin et al.
Defu Yuan et al.
Post-COVID-19 Vaccination (or Long Vax) Syndrome: Putative Manifestation, Pathophysiology, and Therapeutic Options [0.03%]
新冠疫苗接种后(或称“长臂疫苗”)反应综合症:可能的临床表现,病理生理及治疗选择
Shin Jie Yong,Tiff-Annie Kenny,Alice Halim et al.
Shin Jie Yong et al.
With the global rollout of COVID-19 vaccines, vaccine safety remains a priority. Emerging concerns have raised the potential risk of a long COVID-like syndrome following vaccination, informally called long Vax and provisionally termed post-...
The Cerebral Haemorrhage and SARS-CoV-2: An Emerging Virus From a Meta-Analysis Perspective [0.03%]
脑出血与SARS-CoV-2:从荟萃分析的角度看一种新兴病毒的影响
Yuxia Wang,Chao Zhang,Yunzhu Zhang et al.
Yuxia Wang et al.
The central nervous system is a potential target of the COVID-19 virus, and one of the devastating neurological consequences of this infection is cerebral haemorrhage (ICH). Cerebral haemorrhage is a leading cause of death worldwide. This s...
The Role of Neurophysiology in Investigating Neuropathology of Vertical Zika Virus Infection [0.03%]
神经生理学在垂直寨卡病毒感染神经系统病理研究中的作用
Dimitri Marques Abramov,Daniel de Souza E Silva,Adriana Salvio Rios et al.
Dimitri Marques Abramov et al.
Prevalence and the Mutual Relationship Between Chronic Obstructive Pulmonary Disease and Arbovirus: A Comprehensive Systematic Review and Meta-Analysis of Current Evidence [0.03%]
慢性阻塞性肺疾病与虫媒病毒的流行病学及相互关系:现有证据的全面系统综述和meta分析
Xiaodan Li,Shanshan Wang,Xiaoyu Ma et al.
Xiaodan Li et al.
Chronic obstructive pulmonary disease (COPD) is a progressive condition affecting the lungs, marked by persistent respiratory symptoms. The prevalence and the risk of COPD in arboviruses types is not fully addressed clinically. We aim to de...
Crosstalk Between Viral Envelop-E Protein and Host Innate Immune System: Exploring Pharmacological Targets and Agents [0.03%]
病毒包膜E蛋白与宿主先天免疫系统的相互作用:探索药理靶点和药物
Satyam Shekhar,Arvind Maurya,Sandeep et al.
Satyam Shekhar et al.
The Envelope (E)-protein is a key structural element of enveloped viruses that plays a significant role in host-pathogen interactions, viral growth, and hijacking of host innate immune system. Due to lack of antiviral agents and significant...
Immunoinformatics-Driven Design of a Multi-Epitope Vaccine Targeting Simian Virus VP1 Major Capsid Protein for Oncogenic Viral Infection Prevention [0.03%]
基于免疫信息学的多表位疫苗设计用于预防致癌病毒感染——以灵长目病毒VP1衣壳蛋白为主要靶标
Roman Akbar,Shabeen Fatima,Siddiq Ur Rahman et al.
Roman Akbar et al.
Simian Virus (SV) 40 is a DNA virus that remains dormant in the body but occasionally induces tumours in animals. Evidence indicates that SV40 could be crucial in developing certain human cancers. There is no commercial vaccine available ag...